APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

24 December 2025195 pages

Choose your research edition.

Industry ResearchHuman EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit include Yuanma Gene, Shihe Medical, Xiamen Feishuo Biotechnology, Burning Rock, Qiuzhen Medical, Novogene, Jinqirui Biotechnology, BGI and Hangzhou Lianchuan Gene, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market size, projected growth trends, production technologies, key applications, and end-use industries.

Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Segment by Company

Yuanma Gene

Shihe Medical

Xiamen Feishuo Biotechnology

Burning Rock

Qiuzhen Medical

Novogene

Jinqirui Biotechnology

BGI

Hangzhou Lianchuan Gene

TRUPCR

HLB PanaGene

AmoyDx

Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Segment by Type

Sequencing Method

Fluorescence PCR Method

Other

Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Segment by Application

Clinical

Scientific Research

Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Trends Table 2. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Drivers Table 3. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Opportunities and Challenges Table 4. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Restraints Table 5. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share by Manufacturers Table 9. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Manufacturers, Product Type & Application Table 13. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Sequencing Method Table 17. Major Manufacturers of Fluorescence PCR Method Table 18. Major Manufacturers of Other Table 19. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Type (2021-2026) & (K Units) Table 21. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Type (2027-2032) & (K Units) Table 22. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share by Type (2021-2026) Table 23. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share by Type (2027-2032) Table 24. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Type (2021-2026) & (K Units) Table 26. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Type (2027-2032) & (K Units) Table 27. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Market Share by Type (2021-2026) Table 28. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Clinical Table 30. Major Manufacturers of Scientific Research Table 31. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Application (2021-2026) & (K Units) Table 33. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Application (2027-2032) & (K Units) Table 34. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share by Application (2021-2026) Table 35. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share by Application (2027-2032) Table 36. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Application (2021-2026) & (K Units) Table 38. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Application (2027-2032) & (K Units) Table 39. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Market Share by Application (2021-2026) Table 40. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Market Share by Application (2027-2032) Table 41. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Region (2021-2026) & (K Units) Table 43. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share by Region (2021-2026) Table 44. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Country (2021-2026) & (K Units) Table 48. North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Country (2027-2032) & (K Units) Table 49. Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Country (2021-2026) & (K Units) Table 51. Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Country (2027-2032) & (K Units) Table 58. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Market Share by Region (2021-2026) Table 62. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Market Share by Region (2027-2032) Table 63. Yuanma Gene Company Information Table 64. Yuanma Gene Business Overview Table 65. Yuanma Gene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Yuanma Gene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio Table 67. Yuanma Gene Recent Development Table 68. Shihe Medical Company Information Table 69. Shihe Medical Business Overview Table 70. Shihe Medical Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Shihe Medical Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio Table 72. Shihe Medical Recent Development Table 73. Xiamen Feishuo Biotechnology Company Information Table 74. Xiamen Feishuo Biotechnology Business Overview Table 75. Xiamen Feishuo Biotechnology Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Xiamen Feishuo Biotechnology Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio Table 77. Xiamen Feishuo Biotechnology Recent Development Table 78. Burning Rock Company Information Table 79. Burning Rock Business Overview Table 80. Burning Rock Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Burning Rock Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio Table 82. Burning Rock Recent Development Table 83. Qiuzhen Medical Company Information Table 84. Qiuzhen Medical Business Overview Table 85. Qiuzhen Medical Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Qiuzhen Medical Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio Table 87. Qiuzhen Medical Recent Development Table 88. Novogene Company Information Table 89. Novogene Business Overview Table 90. Novogene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Novogene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio Table 92. Novogene Recent Development Table 93. Jinqirui Biotechnology Company Information Table 94. Jinqirui Biotechnology Business Overview Table 95. Jinqirui Biotechnology Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Jinqirui Biotechnology Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio Table 97. Jinqirui Biotechnology Recent Development Table 98. BGI Company Information Table 99. BGI Business Overview Table 100. BGI Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. BGI Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio Table 102. BGI Recent Development Table 103. Hangzhou Lianchuan Gene Company Information Table 104. Hangzhou Lianchuan Gene Business Overview Table 105. Hangzhou Lianchuan Gene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Hangzhou Lianchuan Gene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio Table 107. Hangzhou Lianchuan Gene Recent Development Table 108. TRUPCR Company Information Table 109. TRUPCR Business Overview Table 110. TRUPCR Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. TRUPCR Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio Table 112. TRUPCR Recent Development Table 113. HLB PanaGene Company Information Table 114. HLB PanaGene Business Overview Table 115. HLB PanaGene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. HLB PanaGene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio Table 117. HLB PanaGene Recent Development Table 118. AmoyDx Company Information Table 119. AmoyDx Business Overview Table 120. AmoyDx Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. AmoyDx Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio Table 122. AmoyDx Recent Development Table 123. Key Raw Materials Table 124. Raw Materials Key Suppliers Table 125. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Distributors List Table 126. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Customers List Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Image Figure 2. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size (2021-2032) & (US$ Million) Figure 4. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (2021-2032) & (K Units) Figure 5. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Sequencing Method Image Figure 9. Fluorescence PCR Method Image Figure 10. Other Image Figure 11. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share by Type (2021-2032) Figure 14. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Market Share by Type (2021-2032) Figure 17. Clinical Image Figure 18. Scientific Research Image Figure 19. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share by Application (2021-2032) Figure 22. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Market Share by Application (2021-2032) Figure 25. North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share by Country (2021-2032) Figure 27. U.S. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share by Country (2021-2032) Figure 32. Germany Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share by Country (2021-2032) Figure 39. China Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share by Country (2021-2032) Figure 47. Brazil Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue (2021-2032) & (US$ Million) Figure 58. North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue (2021-2032) & (US$ Million) Figure 60. Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Sequencing Method
  • Fluorescence PCR Method
  • Other
Applications
  • Clinical
  • Scientific Research
Companies covered
  • Yuanma Gene
  • Shihe Medical
  • Xiamen Feishuo Biotechnology
  • Burning Rock
  • Qiuzhen Medical
  • Novogene
  • Jinqirui Biotechnology
  • BGI
  • Hangzhou Lianchuan Gene
  • TRUPCR
  • HLB PanaGene
  • AmoyDx

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Dynamics
  1. 2.1 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Trends
  2. 2.2 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Drivers
  3. 2.3 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Opportunities and Challenges
  4. 2.4 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Restraints
3 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market by Manufacturers
  1. 3.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Manufacturers (2021-2026)
  3. 3.3 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Manufacturers, Product Type & Application
  7. 3.7 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Tier 1, Tier 2, and Tier 3
4 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market by Type
  1. 4.1 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Type Introduction
  2. 4.1.1 Sequencing Method
  3. 4.1.2 Fluorescence PCR Method
  4. 4.1.3 Other
  5. 4.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Type
  6. 4.2.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Type (2021-2032)
  8. 4.2.3 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share by Type (2021-2032)
  9. 4.3 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Type
  10. 4.3.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Type (2021-2032)
  12. 4.3.3 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Market Share by Type (2021-2032)
5 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market by Application
  1. 5.1 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Application Introduction
  2. 5.1.1 Clinical
  3. 5.1.2 Scientific Research
  4. 5.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Application
  5. 5.2.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Application (2021-2032)
  7. 5.2.3 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share by Application (2021-2032)
  8. 5.3 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Application
  9. 5.3.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Application (2021-2032)
  11. 5.3.3 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Market Share by Application (2021-2032)
6 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Region
  1. 6.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Region (2021-2032)
  3. 6.2.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Region (2021-2026)
  4. 6.2.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Region
  1. 7.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Region
  2. 7.1.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Region (2021-2026)
  4. 7.1.3 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Region (2027-2032)
  5. 7.1.4 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue (2021-2032)
  8. 7.2.2 North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue (2021-2032)
  11. 7.3.2 Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Yuanma Gene
  2. 8.1.1 Yuanma Gene Company Information
  3. 8.1.2 Yuanma Gene Business Overview
  4. 8.1.3 Yuanma Gene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Yuanma Gene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
  6. 8.1.5 Yuanma Gene Recent Developments
  7. 8.2 Shihe Medical
  8. 8.2.1 Shihe Medical Company Information
  9. 8.2.2 Shihe Medical Business Overview
  10. 8.2.3 Shihe Medical Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Shihe Medical Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
  12. 8.2.5 Shihe Medical Recent Developments
  13. 8.3 Xiamen Feishuo Biotechnology
  14. 8.3.1 Xiamen Feishuo Biotechnology Company Information
  15. 8.3.2 Xiamen Feishuo Biotechnology Business Overview
  16. 8.3.3 Xiamen Feishuo Biotechnology Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Xiamen Feishuo Biotechnology Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
  18. 8.3.5 Xiamen Feishuo Biotechnology Recent Developments
  19. 8.4 Burning Rock
  20. 8.4.1 Burning Rock Company Information
  21. 8.4.2 Burning Rock Business Overview
  22. 8.4.3 Burning Rock Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Burning Rock Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
  24. 8.4.5 Burning Rock Recent Developments
  25. 8.5 Qiuzhen Medical
  26. 8.5.1 Qiuzhen Medical Company Information
  27. 8.5.2 Qiuzhen Medical Business Overview
  28. 8.5.3 Qiuzhen Medical Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Qiuzhen Medical Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
  30. 8.5.5 Qiuzhen Medical Recent Developments
  31. 8.6 Novogene
  32. 8.6.1 Novogene Company Information
  33. 8.6.2 Novogene Business Overview
  34. 8.6.3 Novogene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Novogene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
  36. 8.6.5 Novogene Recent Developments
  37. 8.7 Jinqirui Biotechnology
  38. 8.7.1 Jinqirui Biotechnology Company Information
  39. 8.7.2 Jinqirui Biotechnology Business Overview
  40. 8.7.3 Jinqirui Biotechnology Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Jinqirui Biotechnology Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
  42. 8.7.5 Jinqirui Biotechnology Recent Developments
  43. 8.8 BGI
  44. 8.8.1 BGI Company Information
  45. 8.8.2 BGI Business Overview
  46. 8.8.3 BGI Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 BGI Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
  48. 8.8.5 BGI Recent Developments
  49. 8.9 Hangzhou Lianchuan Gene
  50. 8.9.1 Hangzhou Lianchuan Gene Company Information
  51. 8.9.2 Hangzhou Lianchuan Gene Business Overview
  52. 8.9.3 Hangzhou Lianchuan Gene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Hangzhou Lianchuan Gene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
  54. 8.9.5 Hangzhou Lianchuan Gene Recent Developments
  55. 8.10 TRUPCR
  56. 8.10.1 TRUPCR Company Information
  57. 8.10.2 TRUPCR Business Overview
  58. 8.10.3 TRUPCR Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 TRUPCR Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
  60. 8.10.5 TRUPCR Recent Developments
  61. 8.11 HLB PanaGene
  62. 8.11.1 HLB PanaGene Company Information
  63. 8.11.2 HLB PanaGene Business Overview
  64. 8.11.3 HLB PanaGene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 HLB PanaGene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
  66. 8.11.5 HLB PanaGene Recent Developments
  67. 8.12 AmoyDx
  68. 8.12.1 AmoyDx Company Information
  69. 8.12.2 AmoyDx Business Overview
  70. 8.12.3 AmoyDx Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 AmoyDx Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
  72. 8.12.5 AmoyDx Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Value Chain Analysis
  2. 9.1.1 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Production Mode & Process
  6. 9.2 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Distributors
  9. 9.2.3 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst